| company_type = Public (NASDAQ: HALO) | |
| Industry | Biopharmaceutical |
|---|---|
| Founded | 1998 |
| Headquarters | San Diego, California, USA |
| Key people | Jonathan E. Lim, President & CEO |
| Products | Biologics |
| Revenue | $ 3,799,521 USD (2007) |
| Employees | 130 |
| Website | www.halozyme.com |
Halozyme Therapeutics, based in San Diego, California, is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets.